bioRxivNeurosciencePreprint
mTOR pathway gene knockout results in mTOR-dependent cellular aggregation
Abstract
Malformations of cortical development (MCD) caused by variants in mTOR pathway genes (MPGs) are a leading cause of drug-resistant epilepsy. Characteristic histopathological features of MPG-associated MCD include cytomegaly and cortical dyslamination often with neurons in abnormally close apposition (aggregates). We hypothesized that cellular aggregation is an mTOR-dependent phenotype. Tsc2, Nprl3, Strad, or Kptn were knocked out (KO) using CRISPR/Cas9 in N2a cells in vitro. Levels of phosphorylated ribosomal S6 protein (PS6; Ser240/244), a marker for mTOR activation, were defined via Western blotting in vitro. Timelapse live-cell imaging was used to observe aggregate formation, with or without mTORC1 inhibition (rapamycin). EdU-base cell proliferation assay and cell death assays were performed to determine whether aggregation was the result of changes in cell cycle or increased cell death. Liquid chromatography-mass spectrometry (LC-MS/MS) was used to define changes in the cell aggregate proteome. Human MCD brain tissue specimens were stained with PS6 to assay mTOR signaling in neuronal clusters. All knockout lines formed multi-cell aggregates compared to control lines within 24-48 hours of plating in vitro. Aggregation was abolished with mTOR inhibitor treatment, establishing the mTOR-dependency of aggregate formation. Aggregation was not driven by cell proliferation, apoptosis/necrosis, or the presence of extracellular DNA in culture media. LC-MS/MS analysis revealed altered expression of protein across KO lines including adhesion molecules (e.g., contactin-3), cytoskeletal proteins (e.g., stathmin-2), and protein processing/transport (e.g., Uevld). Our findings establish aberrant cellular aggregation as an mTOR-dependent phenotype across multiple MPG associated with MCD. Changes in expression of adhesion molecules may contribute to abnormal cell aggregation and cortical lamination in MCD and results in abnormal network formation that leads to seizures. HighlightsO_LIIn human MCD specimens, neurons are frequently observed in clustered groups. C_LIO_LIIn vitro models of mTORopathies show mTOR-dependent changes in cellular aggregation. C_LIO_LIProteomic analysis revealed changes in protein levels in adhesion molecules and other molecules relevant to cellular dynamics and protein transport. C_LI
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Developmental Characterization of Neuronal Migration Anomalies and Axon Proliferation in mTOR pathway-associated Malformations of Cortical Development
Paige B. Hoffman, Matthew N. Svalina, … Allyson Alexander·bioRxiv·Mar 11, 2023
- Comprehensive transcriptomic and proteomic profiling of mTOR-related epilepsy
Kaiyuan Ji, Satoshi Miyashita, … Mikio Hoshino·bioRxiv·Mar 11, 2026
- Modeling mTORopathy-related epilepsy in cultured murine hippocampal neurons using the multi-electrode array
Anouk M. Heuvelmans, Martina Proietti Onori, … Geeske M. van Woerden·Experimental NeurologyPeer-reviewed·Jun 22, 2024
- Single-cell-resolved spatial multi-omics identifies mTOR-driven neuronal and astroglial pathogenicity underlying epileptogenic focal cortical dysplasia
Kazumi Shimaoka, Satoshi Miyashita, … Mikio Hoshino·bioRxiv·Jan 23, 2026
- The mTOR pathway genes mTOR, Rheb, Depdc5, Pten, and Tsc1 have convergent and divergent impacts on cortical neuron development and function
Lena H. Nguyen, Youfen Xu, … Angélique Bordey·bioRxiv·Aug 11, 2023
- Pathogenic MTOR somatic variant causing focal cortical dysplasia drives hyperexcitability via overactivation of neuronal GluN2C NMDA receptors
Louison Pineau, Emmanuelle Buhler, … Nail Burnashev·bioRxiv·Dec 1, 2023